Roshni Ravindranathan

1.3k total citations
17 papers, 1.1k citations indexed

About

Roshni Ravindranathan is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Roshni Ravindranathan has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 11 papers in Oncology and 7 papers in Immunology. Recurrent topics in Roshni Ravindranathan's work include Virus-based gene therapy research (12 papers), CAR-T cell therapy research (11 papers) and Immunotherapy and Immune Responses (7 papers). Roshni Ravindranathan is often cited by papers focused on Virus-based gene therapy research (12 papers), CAR-T cell therapy research (11 papers) and Immunotherapy and Immune Responses (7 papers). Roshni Ravindranathan collaborates with scholars based in United States, Germany and India. Roshni Ravindranathan's co-authors include David L. Bartlett, Zong Sheng Guo, Paweł Kaliński, Zuqiang Liu, Zuqiang Liu, Magesh Sathaiah, Yukai He, Mark E. O’Malley, Mathilde Feist and Congrong Ma and has published in prestigious journals such as Nature Communications, Nature Protocols and Cellular and Molecular Life Sciences.

In The Last Decade

Roshni Ravindranathan

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roshni Ravindranathan United States 12 805 727 432 337 157 17 1.1k
Padma Sampath United States 16 597 0.7× 517 0.7× 327 0.8× 280 0.8× 112 0.7× 19 843
Dominic G. Roy Canada 18 644 0.8× 708 1.0× 391 0.9× 466 1.4× 164 1.0× 31 1.2k
Mari Hirvinen Finland 13 550 0.7× 651 0.9× 236 0.5× 361 1.1× 196 1.2× 19 878
Sari Pesonen Finland 16 629 0.8× 734 1.0× 213 0.5× 448 1.3× 206 1.3× 24 947
Feorillo Galivo United States 17 706 0.9× 1.0k 1.4× 396 0.9× 443 1.3× 156 1.0× 21 1.3k
Johanna K. Kaufmann Germany 13 551 0.7× 497 0.7× 325 0.8× 451 1.3× 90 0.6× 26 1.0k
Mathilde Feist Germany 10 439 0.5× 398 0.5× 203 0.5× 234 0.7× 97 0.6× 15 665
Kyle B. Stephenson Canada 20 767 1.0× 778 1.1× 502 1.2× 385 1.1× 121 0.8× 27 1.3k
Murielle Gantzer France 8 400 0.5× 620 0.9× 209 0.5× 544 1.6× 77 0.5× 13 915
Shyambabu Chaurasiya United States 18 406 0.5× 414 0.6× 128 0.3× 203 0.6× 124 0.8× 33 636

Countries citing papers authored by Roshni Ravindranathan

Since Specialization
Citations

This map shows the geographic impact of Roshni Ravindranathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roshni Ravindranathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roshni Ravindranathan more than expected).

Fields of papers citing papers by Roshni Ravindranathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roshni Ravindranathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roshni Ravindranathan. The network helps show where Roshni Ravindranathan may publish in the future.

Co-authorship network of co-authors of Roshni Ravindranathan

This figure shows the co-authorship network connecting the top 25 collaborators of Roshni Ravindranathan. A scholar is included among the top collaborators of Roshni Ravindranathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roshni Ravindranathan. Roshni Ravindranathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yang, Min, Chao Feng, Mathilde Feist, et al.. (2021). IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity. Cancer Immunology Immunotherapy. 70(9). 2467–2481. 18 indexed citations
2.
Feist, Mathilde, Zhi Zhu, Enyong Dai, et al.. (2020). Oncolytic virus promotes tumor-reactive infiltrating lymphocytes for adoptive cell therapy. Cancer Gene Therapy. 28(1-2). 98–111. 45 indexed citations
3.
Ravindranathan, Roshni, et al.. (2019). Electrolyte Disturbances among Diabetic Patients Admitted in a Multi-specialty Hospital in Southern India. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. 5 indexed citations
4.
Kowalsky, Stacy J., Zuqiang Liu, Mathilde Feist, et al.. (2018). Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade. Molecular Therapy. 26(10). 2476–2486. 118 indexed citations
5.
Obermajer, Nataša, Julie Urban, Eva Wieckowski, et al.. (2018). Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents. Nature Protocols. 13(2). 335–357. 32 indexed citations
6.
Ravindranathan, Roshni, et al.. (2018). Utility of apremilast in the treatment of psoriasis. International Journal of Basic & Clinical Pharmacology. 7(8). 1450–1450. 2 indexed citations
7.
Guo, Zong Sheng, Zuqiang Liu, Magesh Sathaiah, et al.. (2017). Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus. Molecular Therapy — Methods & Clinical Development. 7. 112–122. 10 indexed citations
8.
Liu, Zuqiang, Roshni Ravindranathan, Paweł Kaliński, Zong Sheng Guo, & David L. Bartlett. (2017). Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy. Nature Communications. 8(1). 14754–14754. 289 indexed citations
9.
Downs‐Canner, Stephanie, Zong Sheng Guo, Roshni Ravindranathan, et al.. (2016). Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers. Molecular Therapy. 24(8). 1492–1501. 112 indexed citations
10.
Guo, Zong Sheng, Zuqiang Liu, Roshni Ravindranathan, et al.. (2016). Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer. Oncotarget. 7(16). 22174–22185. 38 indexed citations
11.
Liu, Zuqiang, Roshni Ravindranathan, Jun Li, et al.. (2015). CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy. OncoImmunology. 5(3). e1091554–e1091554. 90 indexed citations
12.
Downs‐Canner, Stephanie, Deepa Magge, Roshni Ravindranathan, et al.. (2015). Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer. Annals of Surgical Oncology. 23(2). 655–662. 33 indexed citations
13.
Bartlett, David L., Zuqiang Liu, Magesh Sathaiah, et al.. (2013). Oncolytic viruses as therapeutic cancer vaccines. Molecular Cancer. 12(1). 103–103. 249 indexed citations
14.
Thirunavukarasu, Pragatheeshwar, Magesh Sathaiah, Michael C. Gorry, et al.. (2013). A Rationally Designed A34R Mutant Oncolytic Poxvirus: Improved Efficacy in Peritoneal Carcinomatosis. Molecular Therapy. 21(5). 1024–1033. 24 indexed citations
15.
Magge, Deepa, et al.. (2013). Inhibitors of C5 complement enhance vaccinia virus oncolysis. Cancer Gene Therapy. 20(6). 342–350. 21 indexed citations
16.
Sathaiah, Magesh, Mark E. O’Malley, Roshni Ravindranathan, et al.. (2011). Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer. Cancer Gene Therapy. 19(3). 192–201. 10 indexed citations
17.
Ravindranathan, Roshni, et al.. (1974). Spontaneous regeneration of the gastrocnemius muscle of the frog,Rana tigrina. Cellular and Molecular Life Sciences. 30(5). 519–520. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Padma Sampath Breakdown of academic impact, for papers by Dominic G. Roy Breakdown of academic impact, for papers by Mari Hirvinen Breakdown of academic impact, for papers by Sari Pesonen Breakdown of academic impact, for papers by Feorillo Galivo Breakdown of academic impact, for papers by Johanna K. Kaufmann Breakdown of academic impact, for papers by Mathilde Feist Breakdown of academic impact, for papers by Kyle B. Stephenson Breakdown of academic impact, for papers by Murielle Gantzer Breakdown of academic impact, for papers by Shyambabu Chaurasiya
Rankless by CCL
2026